ANN ARBOR - Genomic search company Genomenon has hired industry veteran David Anstey as Vice President of Sales. In his new role at Genomenon, Anstey is responsible for building out and leading the company’s sales and business development efforts. “Dave brings 20 years of experience selling into life science companies, and he has an excellent
GRAND RAPIDS — A $500,000 grant from the Grand Rapids SmartZone Local Development Finance Authority will fund a 2 1/2-year program to use 3D printing technology to create medical device parts using medical grade materials and tolerances. The intent to cut the cost and time barriers for medical devices entering the market. More than a
ANN ARBOR — Genomenon announced that it has completed a $2.5 million equity financing round. Company officials said the financing will expand Genomenon’s commercial reach with clinical diagnostic labs, biotech, and pharmaceutical companies. Genomenon connects patient DNA with the evidence in scientific literature to help doctors provide faster and better treatment decisions for patients with
ANN ARBOR - Fifth Eye Inc., a digital health predictive analytics company, has received a $2.36 million investment from Invest Michigan, Biosciences Research and Commercialization Center, and 33 private angel investors. Fifth Eye develops real-time predictive analytic patient data software to give doctors and nurses a heads up hours in advance about impending trouble ranging
ANN ARBOR - Genomenon has struck a co-marketing agreement with Fluidigm Corp. to offer evidence-based genomic panel design services for translational and clinical disease research. Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing, genotyping, and real-time PCR panels for use with highly efficient
ANN ARBOR - GenomeNext has embedded Genomenon’s Mastermind search results in its Olympus Platform to simplify and accelerate variant curation for genomic analysis. Efficacious variant interpretation is a critical but challenging requirement to translate genomics into clinical care and medical discovery. Variant curation remains a very labor-intensive bottleneck often requiring inefficient, manual processes that can
ANN ARBOR—Little hints of immortality are lurking in the stem cells of fruit flies. Stem cells that produce sperm use a genetic trick to stay perpetually young across generations, researchers at the University of Michigan Life Sciences Institute have discovered. Certain sections of the fruit fly genome get shorter with age. But remarkably, some reproductive
ANN ARBOR - The University of Michigan Center for the Discovery of New Medicines has awarded early-stage funding for seven new drug discovery projects by faculty from across U-M. Six of the projects focus on treating disease including heart failure, runaway cell division in cancer, hypertension, Crohn's disease, a genetic heart disorder and neurological damage.
ANN ARBOR - Nine U.S. research universities and a major cancer institute this week announced plans to give would-be life scientists clear, standardized data on graduate school admissions, education and training opportunities, and career prospects. The institutions, which include the University of Michigan, formed the Coalition for Next Generation Life Science in response to the
EAST LANSING - Michigan State University will broaden its research and education partnership with McLaren Health Care, as the medical provider looks to build a new hospital near the university’s campus. “MSU has long enjoyed a close relationship with McLaren, and this new collaboration allows us to explore additional partnerships to jointly deliver health care
